Cite
HARVARD Citation
Martínez-Feito, A. et al. (2022). Early monitoring of infliximab serum trough levels predicts long-term therapy failure in patients with axial spondyloarthritis. Scandinavian journal of rheumatology. pp. 102-109. [Online].